MBAL:CA:TSX-Mackenzie Balanced Allocation ETF (CAD)

ETF | Others |

Last Closing

CAD 23.79

Change

0.00 (0.00)%

Market Cap

CAD 0.08B

Volume

300.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 4.87B
PHYS-U:CA Sprott Physical Gold Trust

+0.01 (+0.06%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.08 (+0.12%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+0.23 (+0.56%)

CAD 3.92B
XEQT:CA iShares Core Equity Portfolio

+0.07 (+0.23%)

CAD 3.86B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.05 (+0.51%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.05 (-0.23%)

CAD 2.78B
NUBF:CA NBI Unconstrained Fixed Income..

+0.02 (+0.10%)

CAD 2.52B

ETFs Containing MBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.31% 60% D- 60% D-
Dividend Return 1.06% 62% D 35% F
Total Return 8.37% 64% D 60% D-
Trailing 12 Months  
Capital Gain 13.34% 61% D- 63% D
Dividend Return 2.12% 77% C+ 40% F
Total Return 15.46% 65% D 63% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.38% 46% F 43% F
Dividend Return 0.48% 46% F 34% F
Total Return 0.10% 56% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 7.19% 55% F 78% C+
Risk Adjusted Return 6.64% 43% F 35% F
Market Capitalization 0.08B 63% D 34% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.